Dr. Lin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-228-1000
Education & Training
Brown UniversityResidency, Internal Medicine, 1994 - 1997
China Medical University ShenyangClass of 1986
Certifications & Licensure
CA State Medical License 1997 - Present
WA State Medical License 2006 - 2024
TX State Medical License 2000 - 2007
Clinical Trials
- A Trial of Maintenance ADAPT Therapy With Capecitabine and Celecoxib in Patients With Metastatic Colorectal Cancer Start of enrollment: 2013 Mar 01
Publications & Presentations
PubMed
- 166 citationsPhase II Study of Capecitabine and Oxaliplatin for Advanced Adenocarcinoma of the Small Bowel and Ampulla of VaterMichael J. Overman, Gauri R. Varadhachary, Scott Kopetz, Rosni Adinin, E. Lin
Journal of Clinical Oncology. 2009-06-01 - 222 citationsEpidermal Growth Factor Receptor Variant III Status Defines Clinically Distinct Subtypes of GlioblastomaChristopher E. Pelloski, Karla V. Ballman, Alfred F. Furth, Li Zhang, E. Lin
Journal of Clinical Oncology. 2007-06-01 - 16 citationsCXC Chemokine Receptor 4 Expression, CXC Chemokine Receptor 4 Activation, and Wild-Type Nucleophosmin Are Independently Associated With Unfavorable Prognosis in Patien...Sergej Konoplev, Pei Lin, Cheng Cameron Yin, E. Lin, Graciela M. Nogueras González
Clinical Lymphoma, Myeloma & Leukemia. 2013-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
